Rakovina Therapeutics Announces Private Placement Offering By Investing.com
VANCOUVER, British Columbia, Nov. 27, 2024 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV, the Company or Rakovina Therapeutics) a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies is pleased to announce a non-brokered private placement offering (the Offering) of up to $1.25 million. The Company has received initial … Read more